Effects of rosiglitazone and metformin on pancreatic beta cell gene expression

Diabetologia

Volumn 49, Issue 4, 2006, Pages 685-696

  Richardson, H ^a   Campbell, S C ^a   Smith, S A ^b   Macfarlane, W M ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Beta cells; FOXA2; IPF1; Metformin; PDX1; Rosiglitazone; Transcription

Indexed keywords

HEPATOCYTE NUCLEAR FACTOR 3BETA; METFORMIN; ORAL ANTIDIABETIC AGENT; ROSIGLITAZONE;

ANIMAL CELL; ARTICLE; CELL FUNCTION; DNA BINDING; DRUG EFFECT; FATTY ACID METABOLISM; GENE EXPRESSION REGULATION; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORT; HYPERGLYCEMIA; INSULIN SENSITIVITY; LIPID METABOLISM; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; TRANSCRIPTION REGULATION; WESTERN BLOTTING;

ACTIVE TRANSPORT, CELL NUCLEUS; ANILIDES; ANIMALS; CELL LINE; CELL NUCLEUS; DNA; GENE EXPRESSION; GLUCOSE; HEPATOCYTE NUCLEAR FACTOR 3-BETA; HOMEODOMAIN PROTEINS; INSULIN-SECRETING CELLS; METFORMIN; MICE; PROINSULIN; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; RATS; THIAZOLIDINEDIONES; TIME FACTORS; TRANS-ACTIVATORS;

EID: 33644820474     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-006-0155-1     Document Type: Article

References (42)

1. Stumvoll M (2003) Thiazolidinediones - some recent developments. Expert Opin Investig Drugs 12:1179-1187
2. Furnsinn C, Waldhausl W (2002) Thiazolidinediones: metabolic actions in vitro. Diabetologia 45:1211-1223
3. Bailey CJ (1992) Biguanides and NIDDM. Diabetes Care 15:755-772
4. Stumvoll M, Nurjhan N, Perriello G et al (1995) Metabolic effects of metformin in non-insulin-dependent diabetes mellitus. N Engl J Med 333:550-554
5. Ovalle F, Bell DS (2004) Effect of rosiglitazone versus insulin on the pancreatic beta-cell function of subjects with type 2 diabetes. Diabetes Care 27:2585-2589
6. Patane G, Piro S, Rabuazzo AM et al (2000) Metformin restores insulin secretion altered by chronic exposure to free fatty acids or high glucose: a direct metformin effect on pancreatic beta-cells. Diabetes 49:735-740
7. Leclerc I, Woltersdorf WW, da Silva Xavier G et al (2004) Metformin, but not leptin, regulates AMP-activated protein kinase in pancreatic islets: impact on glucose-stimulated insulin secretion. Am J Physiol Endocrinol Metab 286:E1023-E1031
8. Kefas BA, Cai Y, Kerckhofs K et al (2004) Metformin-induced stimulation of AMP-activated protein kinase in beta-cells impairs their glucose responsiveness and can lead to apoptosis. Biochem Pharmacol 68:409-416
9. Fryer LG, Parbu-Patel A, Carling D (2002) The anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways. J Biol Chem 277:25226-25232
10. Macfarlane WM, Shepherd RM, Cosgrove KE et al (2000) Glucose modulation of insulin mRNA levels is dependent on PDX1, and occurs independently of changes in intracellular Ca2+. Diabetes 49:418-423
11. Waeber W, Thomson N, Nicod P et al (1996) Transcriptional activation of the GLUT-2 gene by the IPF1/STF1/IDX1 homeobox factor. Mol Endocrinol 10:1327-1334
12. German MS (1993) Glucose sensing in pancreatic islet β-cells: the key role of glucokinase and the glycolytic intermediates. Proc Natl Acad Sci USA 90:1781-1785
13. Macfarlane WM, Smith SB, James RFL et al (1997) The p38/ reactivating kinase mitogen activated protein kinase cascade mediates the activation of the transcription factor insulin upstream factor 1 and insulin gene transcription by high glucose in pancreatic β-cells. J Biol Chem 272:20936-20944
14. Guillemain G, da Silva Xavier G, Rafiq I et al (2004) Importin beta1 mediates the glucose-stimulated nuclear import of pancreatic and duodenal homeobox-1 in pancreatic islet beat-cells (MIN6). Biochem J 15:219-227
15. Kishi A, Nakamura T, Nishio Y et al (2003) Related sumoylation of Pdx1 is associated with its nuclear localization and insulin gene activation. Am J Physiol Endocrinol Metab 284:830-840
16. Campbell SC, Macfarlane WM (2002) Regulation of the pdx1 gene promoter in pancreatic β-cells. Biochem Biophys Res Commun 299:277-284
17. Wu K-L, Gannon M, Peshavaria MM et al (1997) Hepatocyte nuclear factor 3β is involved in pancreatic β-cell-specific transcription of the pdx-1 gene. Mol Cell Biol 17:6002-6013
18. Gerrish K, Gannon M, Shih D et al (2000) Pancreatic β cell-specific transcription of the pdx-1 gene: the role of conserved upstream control regions and their hepatic nuclear factor 3β sites. J Biol Chem 275:3485-3492
19. Marshak S, Benshushan E, Shoshkes M et al (2000) Functional conservation of regulatory elements in the pdx-1 gene: PDX-1 and hepatocyte nuclear factor 3β transcription factors mediate β-cell-specific expression. Mol Cell Biol 20:7583-7590
20. Ben-Shushan E, Marshak S, Shoshkes M et al (2001) A pancreatic β-cell-specific enhancer in the human PDX-1 gene is regulated by hepatocyte nuclear factor 3β (HNF-3 β), HNF-1α, and SPs transcription factors. J Biol Chem 276:17533-17540
21. Miyazaki J, Araki K, Yamato E et al (1990) Establishment of a pancreatic beta cell line that retains glucose-inducible insulin secretion: special reference to expression of glucose transporter isoforms. Endocrinology 127:126-132
22. Shepherd LA, Campbell SC, Macfarlane WM (2004) Transcriptional regulation of the IAPP gene in pancreatic β-cells. Biochim Biophys Acta 1681:28-37
23. Macfarlane WM, McKinnon CM, Felton-Edkins ZM et al (1999) Glucose stimulates translocation of the homeodomain transcription factor PDX1 from the cytoplasm to the nucleus in pancreatic β-cells. J Biol Chem 274:1011-1016
24. Blumentrath J, Neye H, Verspohl EJ (2001) Effects of retinoids and thiazolidinediones on proliferation, insulin release, insulin mRNA, GLUT 2 transporter protein and mRNA of INS-1 cells. Cell Biochem Funct 19:159-169
25. Bailey CJ, Day C (2004) Avandamet: combined metformin-rosiglitazone treatment for insulin resistance in type 2 diabetes. Int J Clin Pract 58:867-876
26. Jones TA, Sautter M, Van Gaal LF et al (2003) Addition of rosiglitazone to metformin is most effective in obese, insulin-resistant patients with type 2 diabetes. Diabetes Obes Metab 5:163-170
27. Lenhard JM, Kliewer SA, Paulik MA et al (1997) Effects of troglitazone and metformin on glucose and lipid metabolism: alterations of two distinct molecular pathways. Biochem Pharmacol 54:801-808
28. Lupi R, Del Guerra S, Marselli L et al (2004) Rosiglitazone prevents the impairment of human islet function induced by fatty acids: evidence for a role of PPARgamma2 in the modulation of insulin secretion. Am J Physiol Endocrinol Metab 286:E560-E567
29. Rafiq I, da Silva Xavier G, Hooper S et al (2000) Glucose-stimulated preproinsulin gene expression and nuclear translocation of pancreatic duodenum homeobox-1 require activation of phosphatidylinositol 3-kinase but not p38 MAPK/SAPK2. J Biol Chem 275:15977-15984
30. Wang X, Cahill CM, Pineyro MA et al (1999) Glucagon-like peptide-1 regulates the beta cell transcription factor, PDX-1, in insulinoma cells. Endocrinology 140:4904-4970
31. Kaneto H, Xu G, Fujii N et al (2002) Involvement of c-Jun N-terminal kinase in oxidative stress-mediated suppression of insulin gene expression. J Biol Chem 277:30010-30018
32. Ishida H, Takizawa M, Ozawa S et al (2004) Pioglitazone improves insulin secretory capacity and prevents the loss of beta-cell mass in obese diabetic db/db mice: possible protection of beta cells from oxidative stress. Metabolism 53:488-494
33. Masamune A, Satoh K, Sakai Y et al (2002) Ligands of peroxisome proliferator-activated receptor-gamma induce apoptosis in AR42J cells. Pancreas 24:130-138
34. Brunmair B, Gras F, Neschen S et al (2001) Direct thiazolidinedione action on isolated rat skeletal muscle fuel handling is independent of peroxisome proliferator-activated receptor-gamma-mediated changes in gene expression. Diabetes 50:2309-2315
35. Iwata M, Haruta T, Usui I et al (2001) Pioglitazone ameliorates tumor necrosis factor-alpha-induced insulin resistance by a mechanism independent of adipogenic activity of peroxisome proliferator-activated receptor-gamma. Diabetes 50:1083-1092
36. Wolfrum C, Besser D, Luca E et al (2003) Insulin regulates the activity of forkhead transcription factor Hnf-3beta/Foxa-2 by Akt-mediated phosphorylation and nuclear/cytosolic localization. Proc Natl Acad Sci USA 100:11624-11629
37. Nishimura W, Salameh T, Kondo T et al (2005) Regulation of insulin gene expression by overlapping DNA binding elements. Biochem 1392:181-189
38. Aramata S, Han SI, Yasuda K et al (2005) Synergistic activation of the insulin gene promoter by the beta-cell enriched transcription factors MafA, Beta2, and Pdx1. Biochim Biophys Acta 1730:41-46
39. Zhao L, Guo M, Matsuoka TA et al (2005) The islet beta cell-enriched MafA activator is a key regulator of insulin gene transcription. J Biol Chem 280:11887-11894
40. Bell DS (2003) Beta-cell rejuvenation with thiazolidinediones. Am J Med 115 Suppl 8A:20S-23S
41. Zeender E, Maedler K, Bosco D et al (2004) Pioglitazone and sodium salicylate protect human beta-cells against apoptosis and impaired function induced by glucose and interleukin-1beta. J Clin Endocrinol Metab 89:5059-5066
42. Walter H, Lubben G (2005) Potential role of oral thiazolidinedione therapy in preserving beta-cell function in type 2 diabetes mellitus. Drugs 65:1-13